Dataset opportunity
Zenflow — 医疗影像数据集机会
Zenflow 持有的中等规模医疗影像数据集，可用于诊断人工智能和计算机视觉。
Score
63.1
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
49%
Action
数据共享协议
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
全球医疗影像人工智能市场 = 2025 年为 18.8 亿美元，复合年增长率为 36.91%。
Recent dated external facts that triggered this opportunity — auditable provenance.
- 📰press2026-10-06
Zenflow raises $52M, inks distribution deal with Cook Medical
medtechdive.com ↗
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Profile
Dataset profile
Type
医疗影像数据集
Modality
影像
Sector
医疗保健
Volume
中等
Freshness
定期
Rarity
高（专有）
Accessibility
受限
Legal
公司所有 — GDPR 敏感（PII 审查）
Buyer persona
医疗人工智能与诊断影像公司
Zenflow 持有大量医疗影像数据集，其影像模态由业务记录、病历和监管文件支持。该精选集已准备好用于开发和验证高精度诊断人工智能算法，提供支持稳健模型训练所需的丰富、多方面数据。
全球医疗影像人工智能市场在2025 年的估值为18.8 亿美元，预计将以 36.91% 的复合年增长率增长。尽管由于高度敏感的PHI和HIPAA等监管限制导致访问复杂，但该数据的稀有性和质量使其成为寻求在此快速扩张市场中获得竞争优势的买家的宝贵资产。⚠ 尽职调查（有价值的数据，可协商的访问权限）：高度敏感的医疗和患者健康信息 (PHI)；受 HIPAA 和 FDA 监管限制；数据可能孤立在临床试验管理系统中 · 公司：独立。
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
这些证据共同证明 Zenflow 拥有来自临床试验的专有医疗影像数据集，该数据集成功支持了FDA 批准。这正是医疗人工智能公司寻求开发和验证针对 BPH 等疾病的诊断人工智能模型所需的高质量、监管级数据。在预计到 2025 年将达到 18.8 亿美元的医疗影像人工智能市场中，访问这样一份稀有、专有的数据集为构建下一代工具提供了显著的竞争优势。
See dimension details ↓- Dataset Specificity78
主导的“病历”，医疗保健行业，2 种特定类型
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity70
专有领域数据
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume52
3 个证据命中
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness46
定期
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value74
适用于诊断人工智能
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand95
买家需求极高，这得益于对高质量、精选医疗影像数据的需求，以利用医疗影像人工智能市场预计 36.91% 的复合年增长率。
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility0
PII/受监管
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility0
高难度，独立
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength62
3 种证据类型，3 次命中
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License62
所有权=公司所有，许可=GDPR 敏感
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
独立
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation22
0 数据胃口信号（0 类型）
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
盈余=高，1 个近期外部信号 — 专有数据超出已货币化的部分
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit100
✓ 良好目标 — Zenflow 是一个理想的目标，因为它是一家制造实体医疗设备的中小企业，并且作为广泛临床试验的副产品，拥有有价值的专有临床结果数据，而这些数据目前并未出售。问题：该公司的核心业务是制造和销售“Spring System”，这是一种用于治疗 BPH 的实体医疗设备，并通过分销协议进行销售；专有数据来自广泛的临床试验（例如 ZEST、BREEZE），包括长期患者结局、症状评分和生活质量；该公司是一家小型企业，员工人数估计在 25 到 50 人之间。[1, 4, 8, 10]；存在与非关联公司名称混淆的情况，特别是“Zenflow by Zencoder”（一款 AI 编码工具）和“Zenflow Pvt. Ltd.”（一家印度的 SaaS 开发商），这
- Deep Qualification90
✓ 通过 — Zenflow 是一个强大的数据持有者候选者。它销售一种经 FDA 批准的用于 BPH 的医疗设备，并且作为其广泛临床试验（ZEST、BREEZE）的副产品，它拥有一个有价值的数据集，包括患者结局和可能的医疗影像，这与最初的假设高度一致。
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Medical records / imaging
这些证据表明数据集包含来自独立临床研究的影像，提供了对真实世界患者结局进行模型训练所必需的临床验证数据。
Regulatory records
这证实了数据集的数据足够稳健，能够支持成功的FDA 批准，使其成为寻求自身未来监管审查的人工智能公司的黄金标准资产，从而降低了开发风险。
business_records
业务记录提供了清晰的商业背景，将数据直接与特定医疗设备（Spring System）联系起来，并展示了其在明确诊断领域的产品级特异性。
Marketplace
Dataset details
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Zenflow Medical Imaging — a Moderate medical imaging dataset (Image modality) in the healthcare domain. Primary AI use-case: Diagnostic AI. Market signal: Global AI in Medical Imaging market = $1.88 billion in 2025, CAGR 36.91% (source: Fortune Business Insights). Investment score 63.1/100 (confidence 0.49). Recommended action: Data Sharing Agreement.
From the marketplace
Explore live data opportunities
Deringer — 监管记录数据集机会
View opportunity →工业Theion — 工业运营数据集机会
View opportunity →工业Rarukautomation — 维护日志数据集商机
View opportunity →